Perennial Holdings Private Limited and Ruijin Hospital have entered into a landmark strategic collaboration aimed at developing a comprehensive international medical services ecosystem anchored in Shanghai. The newly formalized partnership seeks to advance Perennial Hospital Shanghai as a premier destination for high-quality, global-standard medical care, targeting international and domestic patient populations alike. Leaders from both organizations, including Pua Seck Guan, Executive Chairman and CEO of Perennial Holdings, and Qiu Liping, Vice President of Ruijin Hospital, formalized the partnership to align their vision for co-developing innovative medical treatment models, institution-building, and clinical expertise exchange.

At the heart of the collaboration is a commitment to combine the clinical resources, reputation, and experience of Ruijin Hospital—an established tertiary institution recognized for advanced medicine and research—with Perennial Holdings’ robust capabilities in healthcare facility management, cross-border operations, and patient experience design. This fusion aims to create a scalable medical services platform that can be leveraged not only by patients traveling to China for specialized care but also by healthcare professionals seeking advanced training and exposure to international best practices. The integrated service model will involve the co-development of diagnostic and treatment protocols, policy alignment for access to licensed drugs and advanced medical devices, and collaboration on emerging modalities such as cell therapies at Ruijin Hospital’s Hainan branch.

One of the partnership’s defining features is its focus on talent mobility, with the introduction of a dedicated training and exchange program. Medical professionals and hospital management staff will be able to rotate between institutions, giving them direct access to innovations in hospital administration, clinical protocol development, and technology-enabled care delivery. This elevates talent retention, accelerates professional development, and enables the rapid dissemination of cutting-edge knowledge across the organizations, in line with global healthcare standards.

The collaboration’s long-term impact will be felt through the establishment of a dedicated international diagnostics and therapy hub at Perennial Hospital Shanghai. This hub aims to provide seamless access to novel and internationally recognized therapies, facilitate the introduction of licensed pharmaceuticals, and serve as a node for international patient referral and care navigation. Investments in digital health platforms, patient data interoperability, and medical informatics are central to this strategy, ensuring the new ecosystem’s sustainability and competitiveness in Asia’s rapidly evolving medical services market.

Beyond direct patient care, the partnership’s cross-institutional component will foster mutual research initiatives, with particular focus on new diagnostic markers, personalized medicine, and regulatory pathways to facilitate the clinical adoption of emerging treatments. The agreement is also strategically aligned with the Chinese government’s broader push to internationalize its healthcare sector and attract foreign investment and patients. By uniting resources, expertise, and vision, Perennial Holdings and Ruijin Hospital aim to raise the bar for international hospital management standards in the region, ensure compliance with the latest regulatory requirements, and serve the growing demand for high-quality, specialized healthcare among Asia’s increasingly mobile population.

The joint platform is expected to serve as a benchmark for future collaborations in China’s healthcare management landscape, acting as both a magnet for global healthcare investment and as a model for world-class standards in hospital operations, patient services, and healthcare worker development. This move reinforces Shanghai’s role as a rising medical hub for the Asia-Pacific region and demonstrates a proactive private-public approach to healthcare delivery and international patient management, opening new avenues for medical tourism, research, and professional exchange across Asia and beyond.